Today in Tech

The cancer breakthrough that saved his life — and could save thousands more

Jan 27, 2026
Dr. Brandon Mancini, medical director at BAMF Health working in theranostics and AI-driven cancer imaging. Douglas Meijer, Meijer Inc. co-chairman and philanthropist who received theranostics for prostate cancer. They discuss precision-targeted theranostics, traveling for life-saving care, building a local center, AI in imaging and trials, and barriers to wider access.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
ANECDOTE

Traveling Abroad For A Life-Saving Treatment

  • Douglas Meijer traveled to Germany for theranostics after U.S. surgery and radiation couldn't find or remove small tumors.
  • The treatment nearly eliminated tumors and inspired his philanthropic effort to bring the therapy to Grand Rapids.
ANECDOTE

Personal Recovery Sparked Philanthropic Center

  • Douglas Meijer funded and helped build Banff Health after his treatment to bring theranostics to the U.S.
  • He partnered with Michigan State and clinicians to create a center that has treated hundreds or thousands of patients.
INSIGHT

Theranostics Is Targeted 'Guided Missile' Therapy

  • Brandon Mancini explains theranostics merges diagnostics and therapy to target proteins overexpressed on cancer cells.
  • The injected therapy homes to cancer like a guided missile, sparing healthy tissue.
Get the Snipd Podcast app to discover more snips from this episode
Get the app